The U.S. Food and Drug Administration (FDA) has a black-box warning for Veozah, the first hormone-free medication for hot flashes.

Washington

District of Columbia

United States

FDA issues black box warning for hot flash drug Veozah

The US Food and Drug Administration has placed its most serious warning — a so-called black-box warning — on a drug used to relieve menopausal hot flashes.

Ad Fontes Media

All Sides

Media Bias/Fact Check

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

FDA places its most serious warning on menopause drug due to risk of liver injury

News World Communications

(CNN) — The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes. The FDA says women who are taking Veozah may need more frequent blood testing to check for markers of liver problems. In rare cases, the drug may seriously injure the liver, and patients with symptoms including fatigue, unusual itching, nausea, vomiting, light-colored stools, dark uri…

WHDH

Sunbeam Television

Boston

Suffolk County

Massachusetts

FDA places its most serious warning on menopause drug due to risk of liver injury - Boston News, Weather, Sports

(CNN) — The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes.

KWWL

Quincy Media

Gray Television

Waterloo

Black Hawk County

Iowa

By Brenda Goodman, CNN (CNN) — The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes. The FDA says women who are taking Veozah may need more frequent blood testing to check for markers of liver problems. In rare cases, the drug may seriously injure the liver, and patients with symptoms including fatigue, unusual itching, nausea, vomiting, light-c…

KEYT

News-Press & Gazette Company

The FDA has issued its strongest safety alert, a boxed warning, on a menopausal drug linked to severe liver injury.

Medical Daily

Taking Pills For Hot Flashes? FDA Issues Strongest Warning On A Menopausal Drug Linked To Serious Liver Injury

Veozah The symptoms of menopause can have a significant affect on your life, from mood swings to painful periods to joint pain to weight gain. One of the most notorious issues is hot flashes, which can strike at any time. While the Food & Drug Administration (FDA) approved a new drug to fight this occurrence in May 2023, they’ve now placed a Black Box warning on the label due to a rare risk of serious liver damage. On Monday, December 16, the FD…

Scary Mommy

FDA Issues A Black Box Warning For A Popular Menopause Drug

Federal drug regulators have added a "black box" label warning about the potential side effects of Veozah, alerting medical professionals and patients about the risk of rare, but serious, liver injuries linked to the menopause medication. Veozah (fezonlinetant) was approved last year for the treatment of moderate to severe hot flashes during menopause, as part ofÂ  a class of medications known as neurokinin 3 (NK3) receptor agonists, which affec…

aboutlawsuits.com

FDA Adds Veozah Liver Injury Warnings in “Black Box” on Menopause Drug’s Label

An urgent warning has been issued over a common menopause drug over its potentially fatal side effects.  The US drug watchdog, the FDA, has placed its most serious warning, called a black box warning, on the non-hormonal drug fezolinetant, which is sold under the brand name Veozah and is developed by Japanese drugmaker Astellas Pharma. It was approved for marketing in May 2023 to treat hot flashes and night sweats, which are common symptoms of m…

WhatsNew2Day

They Issue The Biggest Possible Warning About A Menopause Drug That Causes Organ Failure

An urgent warning has been issued over a commonly used menopausal drug due to its potentially fatal side effects.  The FDA has posted its most serious warning — a so-called black box warning — for the non-hormonal drug fezolinetant, which is sold under the brand name Veozah and is being developed by Japanese drugmaker Astellas Pharma. It was approved for the market in May 2023 to treat hot flashes and night sweats, which are common symptoms of m…

FDA issues black box warning for hot flash drug Veozah

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics